Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Regulatory
TL;DR
Shuttle Pharma filed an 8-K, standard SEC update, no major news yet.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on January 21, 2025, reporting other events and financial statements. The filing does not contain specific details on new events or financial figures but serves as a notification to the SEC.
Why It Matters
This filing indicates that Shuttle Pharmaceuticals is making a regulatory submission to the SEC, which could relate to ongoing business activities or financial reporting.
Risk Assessment
Risk Level: low — The filing is a routine 8-K without specific material events disclosed, indicating low immediate risk.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- January 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as item information, but the provided text does not detail the specific nature of these events or statements.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on January 21, 2025.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the state of incorporation for Shuttle Pharmaceuticals Holdings, Inc.?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware.
What is the SEC file number for Shuttle Pharmaceuticals Holdings, Inc.?
The SEC file number for Shuttle Pharmaceuticals Holdings, Inc. is 001-41488.
Filing Stats: 949 words · 4 min read · ~3 pages · Grade level 12.7 · Accepted 2025-01-21 09:00:28
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 15KB
- 0001493152-25-002945.txt ( ) — 237KB
- shph-20250121.xsd (EX-101.SCH) — 3KB
- shph-20250121_lab.xml (EX-101.LAB) — 33KB
- shph-20250121_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: January 21, 2025 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer